Medical Services

Cmed Medical Services offers comprehensive and dynamic support to Cmed’s Clinical Services CRO, including:

 

>  Medical and scientific contribution to draft clinical study protocols
    or synopses.

>  Medical and safety monitoring of clinical studies.

Medical writing support.

>  Support to Cmed Consultancy Services.

 

Experience is the difference

Our seasoned medical staff have extensive experience in the pharmaceutical and CRO industry, including:

 

>  All phases of drug development (TM, I-IV) – strongest in first-in-human
   to Phase II POC clinical studies.

> Multiple therapy areas, especially oncology and rare diseases
   immune-inflammation, respiratory and CNS disorders.

> Studies involving a wide variety of compounds including: small molecular
   entities (NCEs), biopharmaceuticals (monoclonal antibodies, antibody
   fragments, antibody drug conjugates and immune check point inhibitors),
   vaccines, cell therapy (including CAR-T cells) and gene therapy products.

 

This group is supported by a network of KOLs and contacts who can provide advice on a project-by-project basis.

 


For more information contact:

 

Bams Abila
Chief Medical Officer
babila@cmedresearch.com
+44 (0)1403 758270